Livent (LTHM) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this supplier of performance lithium compounds would post earnings of $0.04 per share when it actually produced earnings of $0.03, delivering a surprise of -25%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Livent, which belongs to the Zacks Chemical – Specialty industry, posted revenues of $122.9 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 17.65%. This compares to year-ago revenues of $82.2 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Livent shares have added about 2.9% since the beginning of the year versus the S&P 500’s decline of -6.1%.

What’s Next for Livent?

While Livent has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Livent: mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.10 on $107.9 million in revenues for the coming quarter and $0.48 on $502.6 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical – Specialty is currently in the bottom 41% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Ingevity (NGVT), has yet to report results for the quarter ended December 2021. The results are expected to be released on February 23.

This company is expected to post quarterly earnings of $0.71 per share in its upcoming report, which represents a year-over-year change of -46.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Ingevity’s revenues are expected to be $291.5 million, down 10.5% from the year-ago quarter.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.4% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Livent Corporation (LTHM): Free Stock Analysis Report
 
Ingevity Corporation (NGVT): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Artivion (AORT) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.20 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this biological medical device maker would post earnings of $0.05 per share when it actually produced earnings of $0.26, delivering a surprise of 420%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Artivion, which belongs to the Zacks Medical – Instruments industry, posted revenues of $79.39 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 1.79%. This compares to year-ago revenues of $67.9 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Artivion shares have lost about 12.7% since the beginning of the year versus the S&P 500’s decline of -6.1%.

What’s Next for Artivion?

While Artivion has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Artivion: unfavorable. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.08 on $82.2 million in revenues for the coming quarter and $0.21 on $331.45 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical – Instruments is currently in the bottom 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, SeaSpine Holdings (SPNE), has yet to report results for the quarter ended December 2021.

This medical technology company is expected to post quarterly loss of $0.33 per share in its upcoming report, which represents a year-over-year change of +10.8%. The consensus EPS estimate for the quarter has been revised 0.9% higher over the last 30 days to the current level.

SeaSpine Holdings’ revenues are expected to be $54.68 million, up 17.7% from the year-ago quarter.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.4% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Artivion, Inc. (AORT): Free Stock Analysis Report
 
SeaSpine Holdings Corporation (SPNE): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

LTC Properties (LTC) came out with quarterly funds from operations (FFO) of $0.56 per share, missing the Zacks Consensus Estimate of $0.57 per share. This compares to FFO of $0.78 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an FFO surprise of -1.75%. A quarter ago, it was expected that this real estate investment trust would post FFO of $0.57 per share when it actually produced FFO of $0.45, delivering a surprise of -21.05%.

Over the last four quarters, the company has not been able to surpass consensus FFO estimates.

LTC, which belongs to the Zacks REIT and Equity Trust – Other industry, posted revenues of $30.03 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 6.29%. This compares to year-ago revenues of $37.77 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management’s commentary on the earnings call.

LTC shares have added about 1% since the beginning of the year versus the S&P 500’s decline of -6.1%.

What’s Next for LTC?

While LTC has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.

Ahead of this earnings release, the estimate revisions trend for LTC: mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus FFO estimate is $0.61 on $29.49 million in revenues for the coming quarter and $2.50 on $121.37 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust – Other is currently in the bottom 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Service Properties (SVC), another stock in the same industry, has yet to report results for the quarter ended December 2021. The results are expected to be released on February 24.

This real estate investment trust is expected to post quarterly earnings of $0.23 per share in its upcoming report, which represents a year-over-year change of +264.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Service Properties’ revenues are expected to be $397.3 million, up 47.1% from the year-ago quarter.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.4% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
LTC Properties, Inc. (LTC): Free Stock Analysis Report
 
Service Properties Trust (SVC): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Quidel (QDEL) came out with quarterly earnings of $7.29 per share, beating the Zacks Consensus Estimate of $4.89 per share. This compares to earnings of $11.07 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 49.08%. A quarter ago, it was expected that this medical diagnostics company would post earnings of $0.87 per share when it actually produced earnings of $5.36, delivering a surprise of 516.09%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Quidel, which belongs to the Zacks Medical – Products industry, posted revenues of $636.87 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 0.29%. This compares to year-ago revenues of $809.2 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Quidel shares have lost about 31.5% since the beginning of the year versus the S&P 500’s decline of -6.1%.

What’s Next for Quidel?

While Quidel has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Quidel: favorable. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $2.05 on $265.99 million in revenues for the coming quarter and $6.90 on $946.14 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical – Products is currently in the bottom 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

MacroGenics (MGNX), another stock in the same industry, has yet to report results for the quarter ended December 2021. The results are expected to be released on February 24.

This biopharmaceutical company is expected to post quarterly loss of $0.83 per share in its upcoming report, which represents a year-over-year change of -4250%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

MacroGenics’ revenues are expected to be $19.83 million, down 62.4% from the year-ago quarter.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.4% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Quidel Corporation (QDEL): Free Stock Analysis Report
 
MacroGenics, Inc. (MGNX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

America’s Car-Mart (CRMT) came out with quarterly earnings of $2.77 per share, missing the Zacks Consensus Estimate of $2.97 per share. This compares to earnings of $2.85 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of -6.73%. A quarter ago, it was expected that this auto retailer would post earnings of $3.41 per share when it actually produced earnings of $3.33, delivering a surprise of -2.35%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

America’s Car-Mart, which belongs to the Zacks Automotive – Retail and Whole Sales industry, posted revenues of $291.9 million for the quarter ended January 2022, surpassing the Zacks Consensus Estimate by 0.03%. This compares to year-ago revenues of $228.26 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

America’s Car-Mart shares have lost about 2.8% since the beginning of the year versus the S&P 500’s decline of -6.2%.

What’s Next for America’s Car-Mart?

While America’s Car-Mart has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for America’s Car-Mart: mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $3.41 on $309.87 million in revenues for the coming quarter and $12.99 on $1.17 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Automotive – Retail and Whole Sales is currently in the top 3% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the broader Zacks Retail-Wholesale sector, Signet (SIG), has yet to report results for the quarter ended January 2022.

This jewelry company is expected to post quarterly earnings of $4.91 per share in its upcoming report, which represents a year-over-year change of +18.3%. The consensus EPS estimate for the quarter has been revised 1% lower over the last 30 days to the current level.

Signet’s revenues are expected to be $2.77 billion, up 26.6% from the year-ago quarter.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
America’s CarMart, Inc. (CRMT): Free Stock Analysis Report
 
Signet Jewelers Limited (SIG): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Boston Beer (SAM) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of $3.27. This compares to earnings of $2.56 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of -102.75%. A quarter ago, it was expected that this brewer would post earnings of $4.04 per share when it actually produced earnings of $2.97, delivering a surprise of -26.49%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Boston Beer, which belongs to the Zacks Beverages – Alcohol industry, posted revenues of $348.09 million for the quarter ended December 2021, missing the Zacks Consensus Estimate by 20.36%. This compares to year-ago revenues of $460.94 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Boston Beer shares have lost about 16.4% since the beginning of the year versus the S&P 500’s decline of -6.2%.

What’s Next for Boston Beer?

While Boston Beer has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Boston Beer: mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $2.91 on $487.85 million in revenues for the coming quarter and $15.76 on $2.38 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Beverages – Alcohol is currently in the bottom 22% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Molson Coors Brewing (TAP), another stock in the same industry, has yet to report results for the quarter ended December 2021. The results are expected to be released on February 23.

This beer maker is expected to post quarterly earnings of $0.90 per share in its upcoming report, which represents a year-over-year change of +125%. The consensus EPS estimate for the quarter has been revised 15.8% lower over the last 30 days to the current level.

Molson Coors Brewing’s revenues are expected to be $2.54 billion, up 11% from the year-ago quarter.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Boston Beer Company, Inc. (SAM): Free Stock Analysis Report
 
Molson Coors Beverage Company (TAP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Armour Residential REIT (ARR) came out with quarterly earnings of $0.27 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.32 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

A quarter ago, it was expected that this real estate investment trust would post earnings of $0.25 per share when it actually produced earnings of $0.25, delivering no surprise.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

Armour Residential REIT, which belongs to the Zacks REIT and Equity Trust industry, posted revenues of $20.53 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 21.47%. This compares to year-ago revenues of $19.54 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Armour Residential REIT shares have lost about 11% since the beginning of the year versus the S&P 500’s decline of -6.2%.

What’s Next for Armour Residential REIT?

While Armour Residential REIT has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Armour Residential REIT: mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.28 on $17.87 million in revenues for the coming quarter and $1.11 on $78.88 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust is currently in the bottom 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

iStar Financial (STAR), another stock in the same industry, has yet to report results for the quarter ended December 2021. The results are expected to be released on February 24.

This commercial real estate finance company is expected to post quarterly loss of $0.42 per share in its upcoming report, which represents a year-over-year change of -380%. The consensus EPS estimate for the quarter has been revised 7800% higher over the last 30 days to the current level.

iStar Financial’s revenues are expected to be $101.27 million, down 30.7% from the year-ago quarter.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ARMOUR Residential REIT, Inc. (ARR): Free Stock Analysis Report
 
iStar Financial Inc. (STAR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Valmont Industries (VMI) came out with quarterly earnings of $2.73 per share, beating the Zacks Consensus Estimate of $2.65 per share. This compares to earnings of $2.20 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 3.02%. A quarter ago, it was expected that this infrastructure equipment maker would post earnings of $2.43 per share when it actually produced earnings of $2.57, delivering a surprise of 5.76%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Valmont, which belongs to the Zacks Steel – Pipe and Tube industry, posted revenues of $963.28 million for the quarter ended December 2021, surpassing the Zacks Consensus Estimate by 11.17%. This compares to year-ago revenues of $798.38 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Valmont shares have lost about 10.7% since the beginning of the year versus the S&P 500’s decline of -6.2%.

What’s Next for Valmont?

While Valmont has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Valmont: favorable. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $2.85 on $866.6 million in revenues for the coming quarter and $12.36 on $3.72 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Steel – Pipe and Tube is currently in the top 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the broader Zacks Industrial Products sector, Constellium (CSTM), has yet to report results for the quarter ended December 2021. The results are expected to be released on February 23.

This aluminum company is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of -32.1%. The consensus EPS estimate for the quarter has been revised 1.5% lower over the last 30 days to the current level.

Constellium’s revenues are expected to be $1.68 billion, up 13.6% from the year-ago quarter.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Valmont Industries, Inc. (VMI): Free Stock Analysis Report
 
Constellium SE (CSTM): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Bright Horizons Family Solutions (BFAM) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.36 per share a year ago. These figures are adjusted for non-recurring items.

– Zacks

This quarterly report represents an earnings surprise of 4.84%. A quarter ago, it was expected that this child care and early education services provider would post earnings of $0.61 per share when it actually produced earnings of $0.64, delivering a surprise of 4.92%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Bright Horizons, which belongs to the Zacks Schools industry, posted revenues of $462.66 million for the quarter ended December 2021, missing the Zacks Consensus Estimate by 0.74%. This compares to year-ago revenues of $377.08 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Bright Horizons shares have added about 5.7% since the beginning of the year versus the S&P 500’s decline of -6.2%.

What’s Next for Bright Horizons?

While Bright Horizons has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Bright Horizons: favorable. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.74 on $469.55 million in revenues for the coming quarter and $3.63 on $2.22 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Schools is currently in the bottom 45% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Nerdy Inc. (NRDY), another stock in the same industry, has yet to report results for the quarter ended December 2021. The results are expected to be released on February 28.

This company is expected to post quarterly loss of $0.17 per share in its upcoming report, which represents a year-over-year change of +93.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Nerdy Inc.’s revenues are expected to be $41.65 million, up 26.2% from the year-ago quarter.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bright Horizons Family Solutions Inc. (BFAM): Free Stock Analysis Report
 
Nerdy Inc. (NRDY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.